目前的组合治疗方面:质母细胞瘤治疗的未来前景
1Department of Biotechnology, Jaypee Institute of Information Technology, Noida, 201309, India.
Current medical science
|December 18, 2024
概括
质母细胞瘤 (GBM) 治疗仍然不足,尽管结合疗法,但存活率很低. 本综述探讨了当前和新兴的质母细胞瘤治疗选择和替代疗法.
科学领域:
- 神经瘤学神经瘤学
- 癌症治疗治疗 癌症治疗
- 瘤生物学 瘤生物学
背景情况:
- 质母细胞瘤 (GBM) 是一种高度恶性脑瘤,治疗选择不足.
- 目前的治疗方法 (手术,化疗,放射治疗) 由于GBM的异质性,提供了较差的中位生存率.
- 针对瘤细胞的选择性疗法的需要至关重要.
研究的目的:
- 审查目前质母细胞瘤的治疗方法.
- 讨论新兴的治疗策略和针对GBM的创新药物治疗方案.
- 探索替代性质母细胞瘤疗法的前景.
主要方法:
- 临床前和临床试验的文献综述.
- 对当前组合治疗方法的分析.
- 讨论新的治疗目标和治疗方案.
主要成果:
- 质母细胞瘤治疗仍然具有挑战性,标准疗法的有效性有限.
- 组合疗法正在发展,正在研究创新的药物疗法.
- 选择性向瘤细胞对于改善结果至关重要.
结论:
- 尽管有进展,但质母细胞瘤治疗需要进一步的创新.
- 新兴的治疗方法显示出改善患者预后的希望.
- 替代疗法可能为质母细胞瘤管理提供新的途径.
更多相关视频
相关概念视频
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
475
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
475


